GLUCAGON-LIKE-PEPTIDE

European patent · EP3720873 · In force

Register entry

Publication number
EP3720873
Application number
EP18819263
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 4, 2018
Published
Oct 14, 2020
Granted
Dec 4, 2024
Protection ends at the latest
Dec 3, 2038
Next annual fee due
Dec 31, 2026
IPC classes
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
A61K 38/00 (2006.01)
A61P 3/08 (2006.01)
Priority
GB 201720187 04.12.2017
PCT application
PCT/GB2018/053512 04.12.2018
PCT publication
WO2019/110981 13.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Oct 15, 2025

    Change

    Published in Swissreg on 15.10.2025

  3. Mar 6, 2025

    Change

    Published in Swissreg on 06.03.2025

  4. Jan 29, 2025

    Agent entered

    Representative
    RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 29.01.2025

  5. Dec 4, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.12.2024

Parties

Holder

IP2IPO Innovations Limited

Top Floor, The Walbrook Building 25 Walbrook, London EC4N 8AF, GB

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

Inventor

BLOOM, Stephen Robert

London Greater London SW7 2PG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.